Late Ebola virus relapse causing meningoencephalitis: a case report

被引:258
作者
Jacobs, Michael [1 ]
Rodger, Alison [6 ]
Bell, David J. [7 ]
Bhagani, Sanjay [1 ]
Cropley, Ian [1 ]
Filipe, Ana [9 ]
Gifford, Robert J. [9 ]
Hopkins, Susan [1 ]
Hughes, Joseph [9 ]
Jabeen, Farrah [3 ]
Johannessen, Ingolfur [8 ]
Karageorgopoulos, Drosos [1 ]
Lackenby, Angie [10 ]
Lester, Rebecca [1 ]
Liu, Rebecca S. N. [2 ]
MacConnachie, Alisdair [7 ]
Mahungu, Tabitha [1 ]
Martin, Daniel [5 ]
Marshall, Neal [4 ]
Mepham, Stephen [1 ]
Orton, Richard [9 ]
Palmarini, Massimo [9 ]
Patel, Monika [11 ]
Perry, Colin [7 ]
Peters, S. Erica [7 ]
Porter, Duncan [7 ]
Ritchie, David [7 ]
Ritchie, Neil D. [7 ]
Seaton, R. Andrew [7 ]
Sreenu, Vattipally B. [9 ]
Templeton, Kate [8 ]
Warren, Simon [1 ]
Wilkie, Gavin S. [9 ]
Zambon, Maria [10 ]
Gopal, Robin [11 ]
Thomson, Emma C. [7 ,9 ]
机构
[1] Royal Free London NHS Fdn Trust, Dept Infect, London NW3 2QG, England
[2] Royal Free London NHS Fdn Trust, Dept Neurol, London, England
[3] Royal Free London NHS Fdn Trust, Dept Radiol, London, England
[4] Royal Free London NHS Fdn Trust, Dept Pharm, London, England
[5] UCL, Div Surg, London, England
[6] UCL, Res Dept Infect & Populat Hlth, London, England
[7] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland
[8] Royal Edinburgh Infirm, Reg Virus Lab Specialist Virol Ctr, Edinburgh, Midlothian, Scotland
[9] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland
[10] Publ Hlth England, Natl Infect Serv, Virus Reference Dept, Colindale, England
[11] Publ Hlth England, Natl Infect Serv, High Containment Microbiol Dept, Colindale, England
基金
英国惠康基金;
关键词
ARGENTINE HEMORRHAGIC-FEVER; SIERRA-LEONE; DISEASE;
D O I
10.1016/S0140-6736(16)30386-5
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background There are thousands of survivors of the 2014 Ebola outbreak in west Africa. Ebola virus can persist in survivors for months in immune-privileged sites; however, viral relapse causing life-threatening and potentially transmissible disease has not been described. We report a case of late relapse in a patient who had been treated for severe Ebola virus disease with high viral load (peak cycle threshold value 13.2). Methods A 39-year-old female nurse from Scotland, who had assisted the humanitarian effort in Sierra Leone, had received intensive supportive treatment and experimental antiviral therapies, and had been discharged with undetectable Ebola virus RNA in peripheral blood. The patient was readmitted to hospital 9 months after discharge with symptoms of acute meningitis, and was found to have Ebola virus in cerebrospinal fluid (CSF). She was treated with supportive therapy and experimental antiviral drug GS-5734 (Gilead Sciences, San Francisco, Foster City, CA, USA). We monitored Ebola virus RNA in CSF and plasma, and sequenced the viral genome using an unbiased metagenomic approach. Findings On admission, reverse transcriptase PCR identified Ebola virus RNA at a higher level in CSF (cycle threshold value 23.7) than plasma (31.3); infectious virus was only recovered from CSF. The patient developed progressive meningoencephalitis with cranial neuropathies and radiculopathy. Clinical recovery was associated with addition of high-dose corticosteroids during GS-5734 treatment. CSF Ebola virus RNA slowly declined and was undetectable following 14 days of treatment with GS-5734. Sequencing of plasma and CSF viral genome revealed only two non-coding changes compared with the original infecting virus. Interpretation Our report shows that previously unanticipated, late, severe relapses of Ebola virus can occur, in this case in the CNS. This finding fundamentally redefines what is known about the natural history of Ebola virus infection. Vigilance should be maintained in the thousands of Ebola survivors for cases of relapsed infection. The potential for these cases to initiate new transmission chains is a serious public health concern.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 16 条
[1]
[Anonymous], 2016, Ebola Situation Report
[2]
Genome sequence analysis of Ebola virus in clinical samples from three British healthcare workers, August 2014 to March 2015 [J].
Bell, A. ;
Lewandowski, K. ;
Myers, R. ;
Wooldridge, D. ;
Aarons, E. ;
Simpson, A. ;
Vipond, R. ;
Jacobs, M. ;
Gharbia, S. ;
Zambon, M. .
EUROSURVEILLANCE, 2015, 20 (20) :6-10
[3]
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients [J].
Bwaka, MA ;
Bonnet, MJ ;
Calain, P ;
Colebunders, R ;
De Roo, A ;
Guimard, Y ;
Katwiki, KR ;
Kibadi, K ;
Kipasa, MA ;
Kuvula, KJ ;
Mapanda, BB ;
Massamba, M ;
Mupapa, KD ;
Muyembe-Tamfum, JJ ;
Ndaberey, E ;
Peters, CJ ;
Rollin, PE ;
Van den Enden, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S1-S7
[4]
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study [J].
Clark, Danielle V. ;
Kibuuka, Hannah ;
Millard, Monica ;
Wakabi, Salim ;
Lukwago, Luswa ;
Taylor, Alison ;
Eller, Michael A. ;
Eller, Leigh Anne ;
Michael, Nelson L. ;
Honko, Anna N. ;
Olinger, Gene G., Jr. ;
Schoepp, Randal J. ;
Hepburn, Matthew J. ;
Hensley, Lisa E. ;
Robb, Merlin L. .
LANCET INFECTIOUS DISEASES, 2015, 15 (08) :905-912
[5]
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report [J].
Deen, G. F. ;
Broutet, N. ;
Xu, W. ;
Knust, B. ;
Sesay, F. R. ;
McDonald, S. L. R. ;
Ervin, E. ;
Marrinan, J. E. ;
Gaillard, P. ;
Habib, N. ;
Liu, H. ;
Liu, W. ;
Thorson, A. E. ;
Yamba, F. ;
Massaquoi, T. A. ;
James, F. ;
Ariyarajah, A. ;
Ross, C. ;
Bernstein, K. ;
Coursier, A. ;
Klena, J. ;
Carino, M. ;
Wurie, A. H. ;
Zhang, Y. ;
Dumbuya, M. S. ;
Abad, N. ;
Idriss, B. ;
Wi, T. ;
Bennett, S. D. ;
Davies, T. ;
Ebrahim, F. K. ;
Meites, E. ;
Naidoo, D. ;
Smith, S. J. ;
Ongpin, P. ;
Malik, T. ;
Banerjee, A. ;
Erickson, B. R. ;
Liu, Y. ;
Liu, Y. ;
Xu, K. ;
Brault, A. ;
Durski, K. N. ;
Winter, J. ;
Sealy, T. ;
Nichol, S. T. ;
Lamunu, M. ;
Bangura, J. ;
Landoulsi, S. ;
Jambai, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15) :1428-1437
[6]
CURRENT STATUS OF THE TREATMENT OF ARGENTINE HEMORRHAGIC-FEVER [J].
ENRIA, D ;
FRANCO, SG ;
AMBROSIO, A ;
VALLEJOS, D ;
LEVIS, S ;
MAIZTEGUI, J .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1986, 175 (2-3) :173-176
[7]
Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study [J].
Faye, Oumar ;
Andronico, Alessio ;
Faye, Ousmane ;
Salje, Henrik ;
Boelle, Pierre-Yves ;
Magassouba, N'Faly ;
Bah, Elhadj Ibrahima ;
Koivogui, Lamine ;
Diallo, Boubacar ;
Diallo, Alpha Amadou ;
Keita, Sakoba ;
Konde, Mandy Kader ;
Fowler, Robert ;
Fall, Gamou ;
Cauchemez, Simon ;
Sall, Amadou Alpha .
PLOS MEDICINE, 2015, 12 (12)
[8]
Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone [J].
Howlett, Patrick ;
Brown, Colin ;
Helderman, Trina ;
Brooks, Tim ;
Lisk, Durodamil ;
Deen, Gibrilla ;
Solbrig, Marylou ;
Lado, Marta .
EMERGING INFECTIOUS DISEASES, 2016, 22 (01) :150-152
[9]
MAIZTEGUI JI, 1979, LANCET, V2, P1216
[10]
Molecular Evidence of Sexual Transmission of Ebola Virus [J].
Mate, S. E. ;
Kugelman, J. R. ;
Nyenswah, T. G. ;
Ladner, J. T. ;
Wiley, M. R. ;
Cordier-Lassalle, T. ;
Christie, A. ;
Schroth, G. P. ;
Gross, S. M. ;
Davies-Wayne, G. J. ;
Shinde, S. A. ;
Murugan, R. ;
Sieh, S. B. ;
Badio, M. ;
Fakoli, L. ;
Taweh, F. ;
de Wit, E. ;
van Doremalen, N. ;
Munster, V. J. ;
Pettitt, J. ;
Prieto, K. ;
Humrighouse, B. W. ;
Stroeher, U. ;
DiClaro, J. W. ;
Hensley, L. E. ;
Schoepp, R. J. ;
Safronetz, D. ;
Fair, J. ;
Kuhn, J. H. ;
Blackley, D. J. ;
Laney, A. S. ;
Williams, D. E. ;
Lo, T. ;
Gasasira, A. ;
Nichol, S. T. ;
Formenty, P. ;
Kateh, F. N. ;
De Cock, K. M. ;
Bolay, F. ;
Sanchez-Lockhart, M. ;
Palacios, G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) :2448-2454